Does ALISKIREN HEMIFUMARATE Cause Affect lability? 179 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 179 reports of Affect lability have been filed in association with ALISKIREN HEMIFUMARATE (Aliskiren). This represents 35.5% of all adverse event reports for ALISKIREN HEMIFUMARATE.
179
Reports of Affect lability with ALISKIREN HEMIFUMARATE
35.5%
of all ALISKIREN HEMIFUMARATE reports
0
Deaths
174
Hospitalizations
How Dangerous Is Affect lability From ALISKIREN HEMIFUMARATE?
Of the 179 reports, 174 (97.2%) required hospitalization, and 164 (91.6%) were considered life-threatening.
Is Affect lability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALISKIREN HEMIFUMARATE. However, 179 reports have been filed with the FAERS database.
What Other Side Effects Does ALISKIREN HEMIFUMARATE Cause?
Nausea (227)
Fall (214)
Cerebrovascular accident (196)
Anxiety (195)
Fatigue (186)
Confusional state (185)
Muscular weakness (184)
Hemiparesis (181)
Hemiplegia (181)
Muscle spasticity (181)
What Other Drugs Cause Affect lability?
DULOXETINE (2,510)
METFORMIN (291)
AMLODIPINE (274)
METHOTREXATE (266)
ATORVASTATIN (259)
IRBESARTAN (257)
LEVOTHYROXINE (251)
SITAGLIPTIN (244)
ESOMEPRAZOLE (234)
ASPIRIN (224)
Which ALISKIREN HEMIFUMARATE Alternatives Have Lower Affect lability Risk?
ALISKIREN HEMIFUMARATE vs ALISKIREN\HYDROCHLOROTHIAZIDE
ALISKIREN HEMIFUMARATE vs ALIZAPRIDE
ALISKIREN HEMIFUMARATE vs ALLANTOIN
ALISKIREN HEMIFUMARATE vs ALLEGRA
ALISKIREN HEMIFUMARATE vs ALLEGRA 24 HOUR